Ther­mo Fish­er's rev­enue falls in Q2 amid 'chal­leng­ing' cli­mate for biotechs and in Chi­na

Ther­mo Fish­er Sci­en­tif­ic blamed a 3% de­cline in rev­enue in the sec­ond quar­ter to biotechs ex­er­cis­ing more cau­tion with their spend­ing and slow­ing eco­nom­ic ac­tiv­i­ty in Chi­na.

The com­pa­ny’s rev­enue fell to $10.7 bil­lion in Q2, down from $10.9 bil­lion in Q2 of last year.

CEO Marc Casper said on an in­vestor call on Wednes­day morn­ing that the drop was due to the “macro­eco­nom­ic en­vi­ron­ment [be­com­ing] more chal­leng­ing in the quar­ter.” One-third of the de­cline in core rev­enue was due to the low­er eco­nom­ic ac­tiv­i­ty in Chi­na, while oth­er cus­tomers pulled back on spend­ing, pri­mar­i­ly biotechs, CFO Stephen Williamson said. Casper cit­ed high­er in­ter­est rates, cred­it avail­abil­i­ty and over­all cau­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER